Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease.
about
Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactionsApproaches for targeted proteomics and its potential applications in neuroscienceMass spectrometry for the detection of potential psychiatric biomarkersCurrent Awareness on Comparative and Functional GenomicsCrystal Structure of Filamentous Aggregates of Human DJ-1 Formed in an Inorganic Phosphate-dependent MannerDJ-1 isoforms in whole blood as potential biomarkers of Parkinson diseaseBuilding the power house: recent advances in mitochondrial studies through proteomics and systems biology.Proteomic analysis of striatal proteins in the rat model of L-DOPA-induced dyskinesia.Identification of novel proteins affected by rotenone in mitochondria of dopaminergic cellsRegion-specific protein abundance changes in the brain of MPTP-induced Parkinson's disease mouse modelNeuroproteomics as a promising tool in Parkinson's disease research.Cloning, characterization, and functional studies of a human 40-kDa catecholamine-regulated protein: implications in central nervous system disorders.Critical role of truncated α-synuclein and aggregates in Parkinson's disease and incidental Lewy body disease.Alterations in energy metabolism, neuroprotection and visual signal transduction in the retina of Parkinsonian, MPTP-treated monkeysQuantitative proteomic analysis of oligodendrogliomas with and without 1p/19q deletionA proteomic analysis of placental trophoblastic cells in preeclampsia-eclampsia.Bridging molecular genetics and biomarkers in lewy body and related disordersInfluence of RNA interference on the mitochondrial subcellular localization of alpha-synuclein and on the formation of Lewy body-like inclusions in the cytoplasm of human embryonic kidney 293 cells induced by the overexpression of alpha-synuclein.Mitochondrial medicine for aging and neurodegenerative diseasesDissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis.Quantification of the synaptosomal proteome of the rat cerebellum during post-natal development.Dopamine-derived quinones affect the structure of the redox sensor DJ-1 through modifications at Cys-106 and Cys-53Use of proteomics for the identification of novel drug targets in brain diseases.Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol.Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosis.The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates.Proteomics in animal models of Alzheimer's and Parkinson's diseases.Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins.Review: Familial Parkinson's disease--genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease.Proteomic analysis of rat brain mitochondria following exposure to dopamine quinone: implications for Parkinson disease.Proteomic studies of nitrated alpha-synuclein microglia regulation by CD4+CD25+ T cells.Resveratrol protects DAergic PC12 cells from high glucose-induced oxidative stress and apoptosis: effect on p53 and GRP75 localization.The impact of mitochondrial DNA and nuclear genes related to mitochondrial functioning on the risk of Parkinson's disease.Proteomics in Parkinson's disease: current trends, translational snags and future possibilities.Mitochondrial proteomics as a selective tool for unraveling Parkinson's disease pathogenesis.Mammalian mitochondrial proteomics: insights into mitochondrial functions and mitochondria-related diseases.Proteomic analysis of mitochondrial dysfunction in neurodegenerative diseases.Understanding the molecular basis of Parkinson's disease, identification of biomarkers and routes to therapy.To label or not to label: applications of quantitative proteomics in neuroscience research.The Lewy body in Parkinson's disease and related neurodegenerative disorders.
P2860
Q24311624-9363F8E8-08EE-4082-AD3D-46EEB6766DFDQ26786427-CA66F194-6B43-40AE-A73D-E5FEED742FC9Q26852637-C246E282-0E69-453D-8FF8-9084D4473D2FQ27486415-410743B5-5B76-453B-867C-2ED8C5304D09Q27652523-2433ED83-D67B-4367-AF7F-EBE81AB2D8C3Q30529658-F23A4E6D-17CD-4A59-99D6-AD54E646B7BFQ33252676-C9A38D8D-FE49-4145-A207-A4F6684015AAQ33285975-65BA401F-D0E2-4BDC-9EB5-0502CDBE7FC8Q33294492-0DA32DA7-B1BA-45D1-8DA5-A711294010A1Q33810589-C767BC65-1430-4328-95C4-BF914AF750FBQ33821316-211C2CE2-D908-478D-A669-B2474023EFB9Q33838788-8307516A-3BC2-4BAD-AFB8-CDA0BEC18236Q33894382-8AEF4151-15C2-4A38-8183-BD109CB3F3DDQ34990005-120BFC2F-974E-445B-826E-49E65A4C9D93Q35058206-487AFDA2-7663-40B4-8784-8C7F407E4AC7Q35068666-D52B19B2-8148-477B-BAE2-83CCEA9952C7Q35094391-E998C5EB-FCF3-44C8-82A3-2336EA21CFF4Q35160746-6DF55FF2-CE26-4135-8194-7CDC111D42DEQ35606693-E6EA4665-82FF-498B-9DE6-85C4C3D7303BQ35819806-2DE5F442-85A3-4BD4-9E3E-FD7F3CA1D7E9Q35946526-CA67DD3B-EB9B-4119-A0B8-B00B1BDA67A5Q36002833-50C1171A-9736-41D9-ABA2-0AEBB5880A18Q36785927-488D19C0-1F91-455C-952E-272B9B89C143Q36899298-D491C4AB-B63C-4BA8-909B-E5EB57AF36BAQ36953434-6856152E-55EC-4FA4-A9DA-B567CCA2DC45Q37003482-EC7BA0A2-4E18-4C36-9FDC-2FB64C6FC185Q37071539-511C38D0-59CF-42ED-A36F-069ED4002696Q37105161-2868FB9B-E797-4AC8-B48F-FA71B85EBD88Q37151410-1CBB26E1-0EFF-4938-909A-AD4FA7BA34B5Q37269603-E54CA215-E199-4434-9B36-FE795B0AF743Q37355257-3B69EA72-A725-4677-B3F7-C7D8F610E02CQ37470082-66FDD017-9BD6-406C-9FA7-CF6F8D4D0B9CQ37583410-9E667244-9E67-4CC5-8FCD-C8036871B12DQ37685124-D0217436-AAFD-4513-B8EF-EA6C69AC51BCQ37727186-16095C6E-9A0D-40B2-9084-DF8AEAC68D12Q37763932-641A6AF9-BA9B-4C2F-BD48-1C173025F434Q37775036-B926951F-19C2-460B-AF13-DEB7F6B8E5CEQ37775037-5AAC343D-12A0-4BC7-BE44-87A31C593A2EQ37976002-0B2FF353-699B-459A-A6C3-2C9CD2BEB0B5Q38012653-FFBF6D3D-86ED-44ED-8116-806AAEE3B00E
P2860
Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Quantitative proteomic analysi ...... ation and Parkinson's disease.
@en
Quantitative proteomic analysi ...... ation and Parkinson's disease.
@nl
type
label
Quantitative proteomic analysi ...... ation and Parkinson's disease.
@en
Quantitative proteomic analysi ...... ation and Parkinson's disease.
@nl
prefLabel
Quantitative proteomic analysi ...... ation and Parkinson's disease.
@en
Quantitative proteomic analysi ...... ation and Parkinson's disease.
@nl
P2093
P1476
Quantitative proteomic analysi ...... ation and Parkinson's disease.
@en
P2093
Feng-Shiun Shie
Gloria E Meredith
Jing Zhang
Jinghua Jin
P304
P356
10.1016/J.MOLBRAINRES.2004.10.003
P577
2004-11-11T00:00:00Z